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Abstract
For females, menarche is a most significant physiological event. Age at menarche (AAM) is a trait with high genetic
determination and is associated with major complex diseases in women. However, specific genes for AAM variation are
largely unknown. To identify genetic factors underlying AAM variation, a genome-wide association study (GWAS) examining
about 380,000 SNPs was conducted in 477 Caucasian women. A follow-up replication study was performed to validate our
major GWAS findings using two independent Caucasian cohorts with 854 siblings and 762 unrelated subjects, respectively,
and one Chinese cohort of 1,387 unrelated subjects—all females. Our GWAS identified a novel gene, SPOCK (Sparc/
Osteonectin, CWCV, and Kazal-like domains proteoglycan), which had seven SNPs associated with AAM with genome-wide
false discovery rate (FDR) q,0.05. Six most significant SNPs of the gene were selected for validation in three independent
replication cohorts. All of the six SNPs were replicated in at least one cohort. In particular, SNPs rs13357391 and rs1859345
were replicated both within and across different ethnic groups in all three cohorts, with p values of 5.09610
23 and
4.37610
23, respectively, in the Chinese cohort and combined p values (obtained by Fisher’s method) of 5.19610
25 and
1.02610
24, respectively, in all three replication cohorts. Interestingly, SPOCK can inhibit activation of MMP-2 (matrix
metalloproteinase-2), a key factor promoting endometrial menstrual breakdown and onset of menstrual bleeding. Our
findings, together with the functional relevance, strongly supported that the SPOCK gene underlies variation of AAM.
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Introduction
Menarche is a most significant milestone in a female’s
physiological development. It happens when thickened endome-
trial tissue undergoes a sudden death due to fluctuations of
hormone levels. Age at menarche (AAM) has a significant impact
on a woman’s health later in life. For example, early AAM is
associated with breast and endometrial cancers [1,2] and late
AAM increases the risk of Alzheimer’s disease [3] and osteoporosis
[4,5]. Overall, early AAM appear to be more harmful to women’s
health than late AAM. In a cohort containing .61,000 Norwegian
women, it was found that there was an inverse association between
AAM and an all-cause mortality rate, with each year decrease in
AAM associated with an average increase of 2.4% in mortality rate
[6]. The significant health implications of AAM make it an
interesting and important trait to study. Understanding the
determining factors of AAM may shed light on the etiology of
AAM-associated diseases and women’s health in general.
Genetic factors play a dominant role in determination of AAM.
From 50% to 70% variation of AAM can be explained by genetic
factors [7–9]. However, specific genes underlying AAM are largely
unknown. So far, compared with other human complex diseases/
traits, a limited few studies were performed to dissect the genetic
basis of AAM. A few candidate genes were suggested to influence
AAM, e.g., the estrogen receptor alpha (ER-a) and beta (ER-b)
genes [10–12], the SHBG gene [13], the androgen receptor gene
[14], the insulin-like growth factor 1 (IGF-1) gene [15], the
chemokine (C-C-motif) receptor 3 (CCR3) gene [16], and the genes
of CYP family [17–19]. To date, only three genome-wide linkage
studies on AAM were published [9,20,21], including one by our
own group [20]. The studies identified several genomic regions
(e.g., 22q11, 22q13, 16q12, 16q21 and 12q) that may harbor
QTLs (quantitative trait loci) underlying AAM.
A promising strategy to facilitate identification of AAM genes is
a genome-wide association study (GWAS) that takes advantage of
the knowledge of linkage equilibrium (LD) patterns in humans and
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platforms. With high SNP density that makes possible the
detection of culprit DNA changes within a narrow genomic
region, the GWAS approach has demonstrated its great power to
identify novel genes for human complex diseases/traits [22–26].
In this study, we conducted a GWAS to search for novel genetic
factors underlying AAM. Using Affymetrix 500 K array, we
successfully genotyped and analyzed a total of 379,319 SNPs in a
cohort of 477 unrelated women, all ascertained with AAM data.
We identified seven SNPs of a novel gene, SPOCK (Sparc/
Osteonectin, CWCV, and Kazal-like domains proteoglycan),
which were associated with AAM at genome-wide significance
level. We selected six most significant SNPs of the gene and
successfully replicated them within and/or across ethnic bound-
aries in three independent cohorts, including one Chinese cohort
containing .1,300 subjects and two independent Caucasian
cohorts with a total of 1,616 subjects. Our study provides strong
evidence for the gene’s importance in regulation of timing of
menarche.
Results
Analysis for Population Stratification
To detect potential stratification of our GWAS Cohort, we
analyzed the sample using software Structure 2.2 [27]. When 200
randomly selected un-linked markers were used to cluster our
subjects, under all the assigned values (i.e., 2, 3, and 4) for the
assumed number of population strata, k, all the subjects of the
cohort were tightly clustered together, suggesting no population
stratification. The results are shown in Figure S1.
We further tested our GWAS Cohort for population stratifica-
tion using the genomic control method [28]. Based on genome-
wide SNP information, we estimated the inflation factor (l), a
measure for population stratification. Ideally, for a homogeneous
population with no stratification the value of l should be equal or
near to 1.0. In the GWAS Cohort, the estimated value for l was
1.000, which suggested essentially no population stratification and
further confirmed the results achieved through the Structure 2.2
software.
Q/Q Plot Analysis
Using the Q-Q plot, we examined the distribution of the p
values achieved in our GWAS for all the analyzed ,380,000 SNPs
(Figure S2). As shown in the plot, the observed p values match
reasonably well with the expected p values over a wide range of
values of [2LOG10(p)], which is from 0 to ,4.5. Observed p
values gradually depart from expected p values at the extreme tail,
where [2LOG10(p)] is $,4.5. The pattern suggests that our
GWAS association findings were more likely due to true genetic
variation than other reasons such as genotyping errors, sample
relatedness or potential population stratifications.
Association Analyses in GWAS Cohort
We performed genome-wide genotypic association analyses for
AAM in our GWAS cohort. The detailed characteristics for the
study subjects are presented in Table 1. We used the FDR-based q
value to control the genome-wide significance for the identified
SNP markers at the significance level of q=0.05. Using this
threshold, we identified a total of 21 markers of known genes
(Table S1) among a total of ,380,000 tested markers. Of note,
one third (i.e., seven) of these 21 markers belong to the SPOCK
(Sparc/Osteonectin, CWCV, and Kazal-like domains proteogly-
can) gene. We therefore focused our subsequent analyses on this
gene. Table S2 lists the relevant information of all the 130
genotyped SNPs of this gene, including the raw p values achieved,
with the most significant seven SNPs that passed the FDR q
threshold of 0.05 highlighted in bold. For readers’ convenience, we
listed in Table 2 only these seven SNPs, with their detailed FDR q
values. Figure 1 plots the 130 SNPs and Figure 2 the seven most
significant SNPs of the gene, showing negative Log10P values
achieved at these SNPs.
Among these seven SNPs of the SPOCK gene, four are located in
intron 5 and three are located in intron 3 (Table 2). Haplotype
analyses indicated that rs2348186 stands alone with weak LD with
Author Summary
Menarche is a physical milestone in a woman’s life. Age at
menarche (AAM) is related to many common female health
problems. AAM is mainly determined by genetic factors.
However, the specific genes and the associated mecha-
nisms underlying AAM are largely unknown. Here, taking
advantage of the most recent technological advances in the
field of human genetics, we identified multiple genetic
variants in a gene, SPOCK, which are associated with AAM
variation in a group of Caucasian women. This association
was subsequently confirmed not only in two independent
groups of Caucasian women but also across ethnic
boundaries in one group of Chinese women. In addition,
SPOCK has a function in regulating a key factor involved in
menstrual cycles, MMP-2, which provides further support to
our findings. Our study provides a solid basis for further
investigation of the gene, which may help to reveal the
underlying mechanisms for the timing of menarche and for
AAM’s relationship with women’s health in general.
Table 1. Characteristics of the subjects for GWAS and the replication study.
Age Range
GWAS Cohort
(Caucasian)
Replication Cohort I
(Caucasian)
Replication Cohort II
(Caucasian)
Replication Cohort III
(Chinese)
N AAM (yr) N AAM (yr) N AAM (yr) N AAM (yr)
,40 175 13.0 (1.5) 426 12.8 (1.4) 6 12.8 (2.2) 943 13.4 (1.4)
40–50 58 12.7 (1.4) 329 13.0 (1.6) 98 12.6 (1.4) 97 13.7 (1.7)
50–60 37 13.5 (4.6) 77 13.4 (1.6) 247 12.8 (1.5) 174 14.5 (1.8)
$60 207 12.9 (1.4) 22 12.8 (1.5) 411 12.8 (1.5) 173 15.1 (1.9)
Total 477 854 762 1,387
Note: Presented are means (SD).
doi:10.1371/journal.pgen.1000420.t001
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1) containing three SNPs in intron 5, rs7701979, rs13357391, and
rs1859345, and the other (Block 2) containing three SNPs in intron
3, rs10054991, rs12653349, and rs1779700 (Figure 2). These two
blocks have suggestive association with AAM, with Block 1 and
Block 2 achieving p values of 3.20610
24 and 3.43610
24,
respectively (Figure 2). The more detailed haplotype block
structure of the seven SNPs showing both r
2 and D9 matrixes is
presented in Figure S3.
Using each SNP as a covariate, we performed conditional
analysis on the remaining 6 SNPs for their association with AAM.
This analysis is to investigate if there is one SNP among the 7
SNPs of the SPOCK gene, which can explain on its own the
association signals of other 6 SNPs. To simplify the presentation
without losing generality, we only present the results (in Table S3)
for the analyses conditioning on each of the three SNPs,
rs2348186, rs13357391 and rs12653349, which are located at
different haplotype blocks (as shown in Figure S3) and have
relatively low LD between each other. Overall, there is significant
drop of association signals in the conditional analysis as compared
with the regular association analysis, suggesting that the
association signals between these 7 SNPs are highly correlated.
In addition, there is a clear pattern that the stronger the LD
between a SNP and the SNP used as the covariate for conditional
analysis, the larger drop of the association signals for the former
SNP, suggesting the correlation of the association signals between
these 7 SNPs is largely due to the LD between them. However,
there is no SNP that when used as a covariate for conditional
analysis, had made the association signals (achieved in regular
association analysis) disappear for all the remaining 6 SNPs,
suggesting that none of the 7 SNPs can explain on its own the
association signals for all of the other 6 SNPs.
Replication Analyses
Among these seven SNPs, we selected six most significant SNPs
for replication, including four in intron 5 (rs2348186, rs7701979,
rs13357391, and rs1859345) and two in intron 3 (rs10054991 and
rs17779700). The association results achieved in the three
replication cohorts are summarized in Table 3. According to the
results, all the six SNPs were replicated (achieving replication p
values,0.05) in $ one replication cohort and four were replicated
in $ two replication cohorts. In particular, three SNPs in intron 5
(rs7701979, rs13357391 and rs1859345) that formed the Block 1 as
determined in our GWAS (Figure 2) as well as the block itself were
replicated in both of the two Caucasian replication cohorts
(Replication Cohorts I & II) (Table 3). Interestingly, Four SNPs
(rs13357391, rs1859345, rs10054991, and rs17779700), including
two (rs13357391 and rs1859345) in intron 5 and two (rs10054991
and rs17779700) in intron 3, were replicated across ethnic
boundaries in Chinese (Replication Cohort III) (Table 3). Overall,
the strongest replication signals were achieved for the two SNPs in
intron 5, rs13357391 and rs1859345, which were replicated both
within and across ethnic groups in all three replication cohorts,
achieving p values of 5.09610
23 and 4.37610
23, respectively, in
the Chinese replication cohort and combined p values of
5.19610
25 and 1.02610
24, respectively, in the analyses of all
three replication cohorts (Table 3).
Using the linear regression function in SAS (SAS Institute Inc.,
Cary, NC), we estimated the effect sizes of the significant SNPs
detected/replicated in our GWAS and the two replication cohorts
containing random unrelated subjects (Replication Cohorts II and
III). The results of the estimation are presented in Tables 2 and 4.
Since currently there is no convenient method and software to
estimate the effect size for a SNP in a family-based sample, we did
not perform effect size estimation for Replication Cohort I that is
made up of siblings. Based on the analysis, the effect for each of
the SNPs under replication is in the same direction in GWAS as in
our replication cohorts; carriers of the minor allele tend to have a
lower AAM than non-carriers in all the cohorts.
We examined AAM association for the haplotype formed by the
two haplotype blocks, Block 1 (containing rs7701979, rs13357391,
and rs1859345) and Block 2 (containing rs10054991, rs12653349,
and rs17779700), as shown in Figure 2, in our GWAS as well as
three replication cohorts. The results are shown in Table 5.
According to the analysis, two haplotypes formed by the two
blocks achieved p values of ,8.0610
24 in the GWAS Cohort. In
the replication cohorts, the signals were most significant in
Replication Cohort I, where two haplotypes both achieved a p
value of ,0.05. Overall, association signals achieved through the
haplotype analysis were less significant than through single SNP
analysis.
Figure 3 presents the AAM data among both Caucasian and
Chinese subjects of different genotypes at the SNP rs13357391 that
achieved the most significant combined p value in the entire
replication analyses. As shown here, although Chinese subjects
have higher average AAM than Caucasians, the AAM difference
Table 2. SNPs identified in GWAS with genome-wide significant FDR q values.
SNP Name Position Role Allele
1 MAF
2 MAF
3 p value FDR q value SNP effect size
4
b SE R
2 Reference allele
rs2348186 136451658 Intron 5 T/C 0.464 0.492 4.92610
27 0.035 20.821 0.158 0.059 C
rs7701979 136463382 Intron 5 G/T 0.367 0.308 8.03610
26 0.038 20.644 0.144 0.045 T
rs13357391 136468981 Intron 5 T/C 0.344 0.308 5.77610
26 0.038 20.644 0.144 0.044 C
rs1859345 136475319 Intron 5 T/C 0.343 0.308 1.58610
25 0.044 20.624 0.144 0.042 C
rs10054991 136587711 Intron 3 A/G 0.235 0.233 1.20610
25 0.042 20.605 0.143 0.040 G
rs12653349 136593147 Intron 3 A/G 0.237 0.233 1.61610
25 0.044 20.605 0.143 0.040 G
rs17779700 136600692 Intron 3 A/G 0.233 0.208 4.81610
26 0.038 20.604 0.143 0.040 G
1The second allele represents the minor allele of each marker.
2Minor allele frequency calculated in our cohort.
3Minor allele frequency reported for Caucasians in the HapMap CEU.
4The association analysis and estimation for SNP effect size was performed under dominant genetic model.
doi:10.1371/journal.pgen.1000420.t002
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across the two ethnic groups.
Other Analyses
Using Genetic Power Calculator (http://pngu.mgh.harvard.
edu/,purcell/gpc/), we calculated the power of the sample used
in the GWAS. Assuming there are 10 QTLs (quantitative trait loci)
each with an allele frequency of 0.2 and in complete LD with the
SNPs under examination, and each contributing 1.5% variance of
AAM, under the significance level of 5610
27, our sample will
have .70% statistical power to identify at least one such QTL. If
under the significance level of 1610
26, then our sample will have
.80% statistical power to identify at least one such QTL.
Using FASTSNP program, we investigated the potential
functions of the replicated SNPs of the SPOCK gene. According
to the analyses, three replicated SNPs (rs7701979, rs1859345 and
rs17779700) are located at intronic enhancer regions and may
cause change in transcription factor binding efficiency; a ‘‘GRT’’
change at rs7701979 may lead to removal of the binding site for
the transcription factor v-Myb, whereas a ‘‘TRC’’ change at
rs1859345 and an ‘‘ARG’’ change at rs17779700 may lead to
creation of the binding site for the transcription factor GATA-1.
To evaluate in our GWAS dataset previously identified
candidate genes for AAM (including the ER-a and ER-b genes
[10–12], the SHBG gene [13], the androgen receptor gene [14],
the IGF-1 gene [15], the CCR3 gene [16], and the genes of CYP
Figure 1. Association signals of the SPOCK gene SNPs. This figure depicts association signals achieved in Caucasians for all the genotyped SNPs
of the SPOCK gene in our GWAS. The X axis shows the physical position of each SNP. The haplotype block map for the whole span of the SPOCK gene,
showing pairwise LD in D9, was constructed for both Caucasians (CEU) and Chinese Han (CHB) using the Haploview program [54] (http://www.broad.
mit.edu/mpg/haploview/) and the most recent SNP genotype data (HapMap Data Rel 26/phaseIII Nov 08, on NCBI B36 assembly, dbSNP b126) from
HapMap (www.hapmap.org). The seven SNPs circled within the rounded rectangle are those achieving significant genome-wide FDR values (q,0.05),
which are further illustrated in Figure 2.
doi:10.1371/journal.pgen.1000420.g001
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those genes for association with AAM in our GWAS cohort. We
found that three SNPs in or near the CCR3 gene achieved
nominally significant p values; a SNP rs13084656, located in the
promoter region, achieved a p value of 0.039; another SNP
rs2157056, located downstream of the gene, achieved a p value of
6.27610
23; a third SNP rs2373156, located in the intronic region,
achieved a p value of 0.050. For other genes listed above, we did
not find SNPs with positive association signals (p,0.05) in our
GWAS dataset.
The above three CCR3 gene SNPs were not genotyped in the
previous CCR3 candidate gene study for AAM [16], where only 16
other SNPs of the gene were genotyped. To facilitate comparison
between this GWAS and the previous study [16] in terms of CCR3
gene’s association with AAM, we performed an imputation-based
meta-analysis. Based on the genotype data generated in our
GWAS for those SNPs in or surrounding the CCR3 gene, we
imputed a total of 1,380 SNPs to cover the gene and its
neighborhood regions, among which, 9 imputed SNPs were also
genotyped in the previous CCR3 candidate gene study [16]. The
association signals achieved at these 9 imputed SNPs in our
GWAS sample were compared with the signals achieved in the
previous candidate gene study [16] in Table 6. As shown in the
table, the reliability of the imputed genotypes at these 9 SNPs is
evidenced by the similarity between the MAFs (minor allele
frequency) derived from the imputed genotype data in the GWAS
sample and the MAFs derived from the genotype data generated
experimentally in the previous CCR3 candidate gene study [16].
Several imputed SNPs, i.e., rs4987053 in exon 3, rs17217831 in
intron 2, rs13067058 in promoter region, and rs3091309 in intron
1, achieved significant (p,0.05) or marginally significant (p,0.10)
p values in our GWAS sample. In particular, the SNP, rs3091309,
achieved an imputed p value of 0.094 in our GWAS sample and a
p value of 0.006 in the previous study [16]. The direction of the
SNP effects is also the same in the two studies, where carriers of
the minor allele ‘‘A’’ tend to have a lower AAM as compared with
the non-carriers. Using Fisher’s method [29] to combine the two p
values achieved, a p value of 4.78610
23 was obtained for the
overall association of this SNP with AAM in the two studies. Our
meta-analysis results provide further support for the CCR3 gene’s
importance to AAM as suggested in the previous study [16].
Discussion
This study reports the first GWAS of AAM in a Caucasian
cohort. Through this study, we identified a novel gene, SPOCK,
with multiple SNPs associated with AAM variation at the genome-
wide significance level (FDR q value,0.05). Noticeably, a group of
SNPs of the SPOCK gene consistently showed genome-wide
significance at the threshold of genome-wide FDR q,0.05 (Table
S1). Our GWAS and the follow-up independent replication study
corroborated the SPOCK gene’s importance for AAM variation in
both Caucasians and Chinese.
SPOCK is a proteoglycan isolated first in human testes and hence
initially named ‘‘testican’’ [30]. So far, its functions are still largely
unknown. Highly expressed in the brain [31], SPOCK was also
found in other tissues, including cartilage [32], vascular endothe-
lium [33], myoblasts [34], fibroblasts [35], lymphocytes [36], and
neuromuscular junction [37]. Recently, SPOCK was also identified
in the blood [38], suggesting that it may exert its functions at the
systemic level. The most noticeable finding for this gene is its
inhibition of MMP-2 (matrix metalloproteinase-2) activation [39].
Interestingly, MMP-2 was found to be a key factor mediating cyclic
endometrial menstrual breakdown and onset of menstrual
bleeding [40]. Taking into account our association findings,
SPOCK may play an essential role in AAM regulation through its
inhibition of MMP-2. However, the above mechanism is still
speculative and needs extensive functional studies for final
validation.
This study also provided some support for the previous findings
on the CCR3 gene’s importance to AAM [16]. Through
imputation-based association analysis, we identified marginally
significant association signals (p=0.094) in the GWAS sample for
a SNP, rs3091309, that was also associated with AAM in the
previous CCR3 candidate gene study [16], achieving a p value of
0.006. The SNP’s direction of effects for AAM association is also
the same between this GWAS and the previous study [16]. The
Figure 2. Association signals of the seven most significant
SNPs of the SPOCK gene. This figure illustrates the association signals
in our GWAS for the seven SPOCK gene SNPs that achieved significant
genome-wide FDR values (q,0.05). The figure also shows the signals for
two haplotype blocks (Blocks 1 & 2) formed by the SNPs rs7701979,
rs13357391 and rs1859345 (for Block 1) and the SNPs rs10054991,
rs12653349 and rs17779700 (for Block 2). The haplotype block map for
the seven SPOCK gene SNPs, showing pairwise LD in D9,w a s
constructed for both Caucasians (CEU) and Chinese Han (CHB) using
the Haploview program [54] (http://www.broad.mit.edu/mpg/haplo-
view/) and the most recent SNP genotype data (HapMap Data Rel 26/
phaseIII Nov 08, on NCBI B36 assembly, dbSNP b126) from HapMap
(www.hapmap.org).
doi:10.1371/journal.pgen.1000420.g002
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in the two studies reaches 4.78610
23.
Imperfect data collection exists more or less in studies of almost
all human diseases/traits. In our study, the AAM data were
collected through retrospective self-reporting. Statistically, there is
no systematic bias in reporting AAM in studies of this trait.
Therefore, inaccuracy of the AAM recall data may be factored
into random noise in the data collected and may only have a
potential effect to decrease the power for detecting the AAM
genes. However, the inaccuracy, if not systematically biased,
should not render false positive findings.
The overall precision of our AAM data is partially supported by
a high heritability of ,0.60 for AAM as detected in our previous
WGLS of AAM [20], where we used the same approach in AAM
data collection as in the current study. Importantly, such a high
heritability could not be achieved if significant errors and thus
noise existed in the AAM data of our study subjects. The reliability
of our AAM data is further supported by our replication results. As
shown in Table 1, our GWAS findings were achieved in a cohort
mostly composed of aged subjects (with ages .50 years). However,
we replicated our most significant GWAS findings using cohorts
containing mainly younger subjects. Our largest replication
cohort, the Chinese cohort, has ,70% subjects younger than
40. Our second largest replication cohort, the Replication Cohort
I, has ,50% subjects younger than 40 and ,90% subjects
younger than 50. The success in replicating findings mainly from
older subjects using mostly younger subjects implicates the high
reliability of AAM recollection for our study subjects.
Our GWAS sample was initially designed for studying not only
AAM but also other complex diseases/traits, such as osteoporosis,
obesity, and human height. The original sample contained 1,000
subjects, with ,500 females and ,500 males, who have multiple
phenotypes such as bone mineral density, body mass index, fat
mass, lean mass, and height, etc [41,42]. Among the subjects, only
477 females have well-substantiated AAM phenotype and can be
used for a GWAS study of AAM. Therefore, our GWAS cohort
contains only 477 subjects. Due to polygenic nature of AAM and
therefore, the existence of multiple QTLs for the trait, even with
such a small size, our GWAS sample may still have a reasonable
power to detect at least one of the QTLs (see the detailed power
calculation in the Results Section). This is evidenced by our
success in identifying the SPOCK gene using the sample. Moreover,
the robustness of our finding on the gene is testified by its
replication in several other cohorts.
Nevertheless, the small size of the GWAS cohort is still an
limitation of our study, which may have limited the statistical
Table 3. Association signals of SNPs under replication.
SNP name Allele
Replication Cohort I
(Caucasian)
Replication Cohort
II (Caucasian)
Replication Cohort III
(Chinese)
Combined p values in 2
Caucasian replication
cohorts
Combined p values
in all 3 replication
cohorts
MAF p value MAF p value MAF p value Fisher’s UNPHASED
rs2348186 T/C 0.481 0.15 0.479 0.048 – – 0.043 9.12610
23 –
*rs7701979 G/T 0.297 0.024 0.297 0.049 – – 9.11610
23 0.24 –
*rs13357391 T/C 0.303 0.011 0.305 7.50610
23 0.160 5.09610
23 8.58610
24 3.75610
24 5.19610
25
*rs1859345 T/C 0.307 0.015 0.305 0.014 0.163 4.37610
23 1.99610
23 9.16610
24 1.02610
24
rs10054991 A/G 0.202 0.27 0.200 0.057 0.123 0.028 0.080 0.035 0.017
rs17779700 A/G 0.203 0.33 0.198 0.045 0.138 0.022 0.077 0.053 0.013
Block 1 – – 0.014 – 0.021 – –– – –
Block 1 is formed by the three neighboring SNPs in intron 5 marked with asterisks. The second allele represents the minor allele of each marker. MAF, minor allele
frequency calculated based on the genotypes of our study subjects. Marked in bold are the replication p values less than 0.05. Combined p values in 2 Caucasian
replication cohorts were calculated using Fisher’s method [29] or using the UNPHASED software (through association analysis on pooled sample containing the two
cohorts) [58]. Combined p values in all 3 replication cohorts were calculated using Fisher’s method only. The two SNPs, rs2348186 and rs7701979, deviate from HWE
(p,0.001) in the Chinese cohort and hence were excluded from association analyses. The association analysis for Replication Cohorts I and II was performed under the
dominant model. The analysis for Replication Cohort III was performed under the recessive model.
doi:10.1371/journal.pgen.1000420.t003
Table 4. Magnitude and direction of SNP effects in Replication Cohorts II and III.
SNP name Replication Cohort II (Caucasian) Replication Cohort III (Chinese) Reference allele
b SE R
2 b SE R
2
rs2348186 20.215 0.140 0.005 – – – C
rs7701979 20.159 0.125 0.003 – – – T
rs13357391 20.267 0.123 0.009 20.709 0.271 0.005 C
rs1859345 20.245 0.124 0.008 20.791 0.262 0.007 C
rs10054991 20.237 0.129 0.006 20.784 0.393 0.003 G
rs17779700 20.232 0.128 0.006 20.694 0.333 0.003 G
The two SNPs, rs2348186 and rs7701979, deviate from HWE (p,0.001) in the Chinese cohort and hence were excluded from association analyses. The estimation for SNP
effect size for Replication Cohort II was performed under the dominant model. The analysis for Replication Cohort III was performed under the recessive model.
doi:10.1371/journal.pgen.1000420.t004
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AAM. In addition, the detailed mechanism of the identified gene,
SPOCK, on AAM regulation is still unclear and therefore, the
direct functional relevance of the gene to AAM cannot be fully
determined. To address the above limitations, our future research
will be directed to the following aspects. First, a new GWAS needs
to be implemented on a larger sample to identify more
comprehensively novel genes for AAM. Second, data from this
study will be shared with other groups in the AAM research
community to build a larger dataset for a GWAS-based meta-
analysis. Lastly, further functional and molecular studies will be
performed on the SPOCK gene to analyze and reveal the specific
mechanisms of the gene in regulating timing of menarche.
In summary, we identified a novel gene, SPOCK, for AAM
through a GWAS and replicated both within and across ethnicity
its association with AAM in independent cohorts. Functional
relevance of SPOCK to AAM is supported by its well documented
role in inhibition of a menstrual proteinase, MMP-2. Our finding
furnishes a solid basis for further molecular and functional analyses
of the gene to pursue its more detailed functions in regulating
timing of menarche and women’s health in general.
Materials and Methods
Study Populations
The study was approved by the Institutional Review Board
and/or the Department of Research Administration of the
involved institutions. Signed informed-consent documents were
obtained from all study participants before they entered the study.
A cohort containing 477 unrelated women (i.e., GWAS Cohort)
was selected for our GWAS from our established and expanding
genetic repertoire currently containing more than 6,000 subjects
recruited in Midwestern USA in Omaha, NE and its surrounding
areas. For replication of our GWAS findings, we selected two
Table 5. Association analysis of haplotypes formed by SNPs of the SPOCK gene.
Cohort
Component SNPs of a
Haplotype Haplotype Haplotype Frequency p value for AAM association
GWAS Cohort SNPs 1-2-3-4-5-6 G-A-T-T-T-A 0.605 7.90610
24
T-G-C-C-C-G 0.197 8.04610
24
Replication Cohort I SNPs 1-2-3-4-6 G-C-T-A-G 0.677 0.038
T-C-C-A-A 0.123 0.015
Replication Cohort II SNPs 1-2-3-4-6 G-A-T-A-T 0.659 0.069
T-G-C-G-C 0.166 0.093
Replication Cohort III SNPs 2-3-4-6 A-A-C-C 0.066 0.051
A-A-T-T 0.786 0.054
SNP1: rs7701979, SNP2: rs13357391; SNP3: rs1859345; SNP4: rs10054991; SNP5: rs12653349;S N P 6 :rs17779700. The haplotype covers the two haplotype blocks, Block 1
and Block 2, as shown in Figure 1. SNP 5 was not genotyped in Replication Cohorts I and II, and SNPs 1 and 5 were not genotyped in Replication Cohort III. Therefore,
these SNPs were not included as the component SNPs for the haplotype analysis for the Replication Cohorts.
doi:10.1371/journal.pgen.1000420.t005
Figure 3. Comparison of AAM among subjects of different genotypes at rs13357391. Presented in the figure are the means and standard
errors of AAM for specific genotype groups in the GWAS and Chinese replication cohorts.
doi:10.1371/journal.pgen.1000420.g003
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containing 854 siblings (Replication Cohort I) and another
containing 762 unrelated women (Replication Cohort II). The
inclusion criteria for the above cohorts include: 1) Caucasians of
European origin; 2) healthy female subjects with regular menses or
if postmenopausal, with a history of regular menses throughout the
years before menopause; and 3) without diseases and conditions
that may potentially affect regular menstrual cycles, as listed in the
exclusion criteria. The detailed exclusion criteria were published
elsewhere [43,44]. Briefly, subjects with chronic diseases and
conditions involving vital organs (heart, lung, liver, kidney, and
brain) and severe endocrinological, metabolic, and nutritional
diseases that might affect regular menstrual cycles were excluded
from this study. The general relevant characteristics of the study
subjects are listed in Table 1. The above three cohorts were
selected based on the criterion that the subjects in different cohorts
should not overlap or be related. Therefore, these three cohorts,
although selected from the same large genetic repertoire
containing 6,000 subjects, are independent and unrelated.
Another cohort from China (Replication Cohort III) was also
used to replicate our GWAS findings and to assess ethnic
specificity/generality of the findings in Caucasians. The cohort
contains unrelated 1,387 female subjects of Chinese Han ethnicity
recruited from Cities of Changsha and Xi’an and their
surrounding areas. Except for the requirement for recruiting
subjects of Chinese Han ethnicity, the inclusion and exclusion
criteria for Replication Cohort III were the same as for our
Caucasian subjects. The general relevant characteristics of these
Chinese study subjects are also listed in Table 1.
AAM data of all the female subjects in the above four cohorts
(i.e., the GWAS Cohort and Replication Cohorts I, II & III) were
collected based on a same standard nurse-administered question-
naire, which included a detailed medical and female history. In
particular, the questionnaire administered to the Chinese subjects
was the accurate Chinese translation of the original questionnaire
used by the Caucasian subjects. All the study subjects reported
their AAM to the accuracy of one year. (Although the raw AAM
data are integers, in Table 1 and Figure 3, the AAM values
presented are not, which is caused by averaging the raw AAM
data among subjects in a certain group.)
Unlike for other traits, recollection by subjects is a generally
reliable measure for AAM data collection. This is because AAM is
a most significant event in female puberty, which often has a major
impact on a woman’s life, both physically and psychologically. A
recent study found a high correlation of ,0.80 between the
original AAM and the AAM recalled even 30 years later [45].
Consistent with the finding, several other studies also indicated
reliability of the retrospective method in AAM data acquisition
[46–48]. Therefore, our study followed this common practice in
the field, which is feasible, convenient and accurate to perform.
Genotyping
Genotyping for the GWAS Cohort. Genomic DNA was
extracted from whole human blood using a commercial isolation
kit (Gentra systems, Minneapolis, MN, USA) following the
protocols detailed in the kit. Genotyping with the Affymetrix
Mapping 250 k Nsp and Affymetrix Mapping 250 k Sty arrays
was performed using the standard protocol recommended by the
manufacturer. Genotyping calls were determined from the
fluorescent intensities using the DM algorithm with a 0.33 P-
value setting [49] as well as the B-RLMM algorithm [50]. DM
calls were used for quality control while the B-RLMM calls were
used for all subsequent data analysis. B-RLMM clustering was
performed with 94 samples per cluster.
In our GWAS genotyping experiment, following an Affymetrix
guideline, we set a standard for the minimum DM call rate at 93%
(or the maximum genotype missing rate at 7%) for a sample,
considering all the SNPs in the two arrays, the 250 k Nsp and 250 k
Sty arrays. More than 98% of all the subjects (i.e., 470 subjects
among a total of 477 subjects) met this call rate standard. The
remaining 7 samples that did not meet this standard however had
one hybridized array passing or approaching this call rate standard
(i.e., 93% of all the SNPs in the array were successfully called).
Hence the genotype data in the array (with the higher call rate) for
these7sampleswerealsokeptinthedatasetforGWASanalysis.For
all the 477 subjects, the average DM call rate reached .95%.
Table 6. Comparison between previous study and this GWAS for CCR3 gene’s association with AAM.
SNP name Results in the previous study [16]
Imputed results in GWAS
sample
Position Role Allele
1 MAF
2 MAF
3 p value MAF
4 p value
rs13067058 46248770 promoter G/A 0.074 0.067 0.142 0.076 0.066
rs1388604 46251882 promoter T/A 0.365 0.325 0.748 0.345 0.921
rs6441948 46270781 intron 1 G/A 0.443 0.479 0.009 0.446 0.200
rs3091309
5 46278188 intron 1 G/A 0.191 0.208 0.006 0.200 0.094
rs1491962 46279610 intron 2 T/C 0.445 0.460 0.03 0.448 0.277
rs17217831 46280445 intron 2 C/A 0.073 0.067 0.151 0.076 0.050
rs4987053 46281704 exon 3 T/C 0.075 0.067 0.663 0.077 0.031
rs3091312 46283476 downstream T/A 0.249 0.250 0.503 0.256 0.858
rs1027241 46287543 downstream G/A 0.446 0.400 0.06 0.450 0.301
1The second allele represents the minor allele of each marker.
2Minor allele frequency calculated in the sample of the previous study [16].
3Minor allele frequency reported for Caucasians in the HapMap CEU.
4Minor allele frequency calculated based on imputed genotypes.
5The direction of the effects for the SNP, rs3091309, is the same in the previous study as in the GWAS sample according to the imputation results, where carriers of the
minor allele ‘‘A’’ tend to have a lower AAM as compared with the non-carriers. Using Fisher’s method [29] to combine the two p values achieved in the previous and the
current GWAS samples, a p value of 4.78610
23 is obtained for the overall association of this SNP with AAM in the two datasets.
doi:10.1371/journal.pgen.1000420.t006
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reached a high level of 99.14%. However, out of the initial full-set
of 500,568 SNPs, we discarded 32,961 SNPs with sample call rate
,95%, another 36,965 SNPs with allele frequencies deviating
from Hardy-Weinberg equilibrium (HWE) (P,0.001) and 51,323
SNPs with minor allele frequencies (MAF) ,1%. Therefore, the
final SNP set maintained in the subsequent analyses contained
379,319 SNPs, yielding an average marker spacing of ,7.9 kb
throughout the human genome.
Genotyping for Caucasian replication cohorts
(Replication Cohorts I & II). Among the seven SNPs of the
SPOCK gene that were found to be associated with AAM in our
GWAS analyses, we genotyped six most significant SNPs in our
two Caucasian replication cohorts (Replication Cohorts I & II).
Genotyping was performed by KBioscience (Herts, UK) using a
modified TaqMan-based assay. The detailed description of the
genotyping method can be found at the company’s website
(http://kbioscience.co.uk/). An average genotyping call rate of
97.8% was achieved. In addition, the genotyping duplicate
concordance rate was 99.7%. All the six SNPs genotyped were
in HWE (p.0.05).
Genotyping for Chinese replication cohort. The same set
of SNPs genotyped in the Caucasian replication cohorts was also
genotyped in our Chinese replication cohort (Replication Cohort
III). Genotyping was performed using a primer extension method
with MALDI-TOF mass spectrometry on a MassARRAY system
(Sequenom, Inc., San Diego, CA). An average genotyping call rate
of 98.7% was achieved and the genotyping duplicate concordance
rate was 99.2%. Two of the six genotyped SNPs (rs2348186 and
rs7701979) were not in HWE (p,0.001) and therefore were
excluded from further association analyses.
Statistical Analyses
Analysis for potential population stratification. To
detect population stratification that could lead to spurious
association results in GWAS analyses, Structure 2.2 (http://
pritch.bsd.uchicago.edu/software.html) was used to investigate the
potential substructure of our GWAS Cohort. The program uses a
Markov chain Monte Carlo (MCMC) algorithm to cluster
individuals into different cryptic sub-populations on the basis of
multi-locus genotype data [51]. To ensure robustness of our
results, we performed independent analyses under three assumed
numbers of population strata, k (i.e., 2, 3, and 4), respectively,
using 200 un-linked markers randomly selected genome-wide.
To confirm the results achieved through Structure 2.2, we
further tested population stratification of our GWAS Cohort using
a method of genomic control [28].
Q-Q plot analysis. We examined the distribution of the p
values for all the analyzed ,380,000 SNPs in our cohort using the
quantile-quantile (Q-Q) plot. The Q-Q plot is for assessing the
magnitude of and validating observed associations, compared with
the expectations under no association. The plot is constructed with
the observed association statistics (e.g., the t statistic) or 2log10P
values ranked in order from smallest to largest on the Y-axis and
plotted against the null distribution (expected under the null
hypothesis of no association) on the X-axis. A deviation from the
identity line at lower expected values of 2log10P or a test statistic
may be due to reasons other than true associations, such as
genotyping errors, sample relatedness or potential population
stratifications.
Adjustment for secular trend. We did not detect a secular
trend of AAM in our Caucasian cohorts (including the GWAS
Cohort and Replication Cohorts I & II). However, a significant
secular trend was detected in our Chinese replication cohort (i.e.,
Replication Cohort III). As shown in Table 1, on average, older
Chinese subjects have higher AAM than their younger
counterparts. To correct for this secular trend, we used MiniTab
(Minitab Inc., State College, PA) software’s linear regression
function and adjusted the AAM raw data using age as a covariate
for the Chinese subjects before association analyses. After such
adjustment, older Chinese subjects will have lower AAM as
compared to their raw AAM data, which may remove the
confounding effects of the secular trend for AAM.
GWAS association analysis. Genome-wide association
analyses, including genotypic association analyses and haplotype
association analyses, were performed using HelixTree 5.3.1
(Golden Helix, Bozeman, MT). For the genotypic association
analyses, linear regression was used as the basic statistical
framework, where genotype was treated as the independent
variable and AAM as the dependent variable, and AAM was
modeled as a linear function of alternative genotypes at a certain
SNP. For the haplotype association analyses, ‘‘sliding window’’
haplotype association test was implemented under the framework
of the haplotype trend regression (HTR) approach [52]. Within
the framework, along each chromosome a certain number of
consecutive SNPs (a ‘‘sliding window’’) can be selected to infer the
haplotype probability for each individual based on the composite
haplotype method [53]. Then, an HTR model was constructed
and used to evaluate the association of AAM with a haplotype
encompassing the selected SNPs.
The LD patterns of the interested genes were analyzed and
plotted using the Haploview program [54] (http://www.broad.
mit.edu/mpg/haploview/) and the most recent SNP genotype
data (HapMap Data Rel 23a/phaseII Mar 08, on NCBI B36
assembly, dbSNP b126) from HapMap (www.hapmap.org).
We adopted a method proposed by Storey and Tibshirani [55]
and used the related software QVALUE (http://genomine.org/
qvalue/) to calculate an FDR (false discovery rate)-based q value
for each tested SNP to evaluate the statistical significance at the
genome-wide level for the GWAS results.
We investigated if there is one SNP among the 7 identified SNPs
of the SPOCK gene, which can explain on its own the association
signals of other 6 SNPs. Using each of the SNPs as a covariate, we
performed conditional analysis on the remaining 6 SNPs for their
association with AAM. The analysis was implemented with the
software MiniTab (Minitab Inc., State College, PA).
Replication analysis. Association analyses for SNP
replication data were performed using HelixTree 5.3.1 (Golden
Helix, Bozeman, MT) on the three independent replication
cohorts. For Replication Cohorts II and III, genetic association
analysis was performed in the same fashion as for the GWAS
cohort, where linear regression analysis was performed modeling
genotype as the independent variable and AAM as the dependent
variable. For the Replication Cohort I, a family-based cohort,
genetic association analysis was performed using the PBAT
package of the HelixTree, which analyzes association signals by
correlating transmission of parental genotype to offspring with
AAM.
Using HBAT in FBAT (ver. 2.02) (http://biosun1.harvard.edu/
,fbat/fbat.htm) [56] and PLINK (ver. 1.03) (http://pngu.mgh.
harvard.edu/purcell/plink/) [57], we performed haplotype-based
association analysis for Replication Cohort I and Replication
Cohorts II and III, respectively.
To quantify the overall evidence of association in the entire
replication analyses, Fisher’s method [29] was used to combine the
individual p values achieved in each of the replication cohorts. The
method, also known as Fisher’s combined probability test, is a
meta-analysis technique for combining the results from indepen-
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[29]. The method combines p values from different studies into
one test statistic that has a chi-square distribution using the
formula X2
2k~{2
P k
i~1
loge pi ðÞ . The p value for the X
2 statistic can
be extrapolated from a chi-square table using 2k ‘‘degree of
freedom’’, where k is the number of tests being combined.
To explore another method for combining the individual p
values achieved in the two Caucasian replication cohorts
(Replication Cohorts I and II), we pooled the two cohorts together
and analyzed the pooled sample for association with AAM using
the software, UNPHASED that allows for genetic association
analysis of a sample containing both un-related (Replication
Cohort II) and related subjects (Replication Cohort I) [58].
Using the linear regression model function in SAS (SAS
Institute Inc., Cary, NC), we estimated the effect sizes of the
significant SNPs detected/replicated in our GWAS and the two
replication cohorts containing random unrelated subjects (Repli-
cation Cohorts II and III).
SNP functional analysis. To explore potential functions of
the significant SNPs identified, we used FASTSNP (function
analysis and selection tool for single nucleotide polymorphisms)
(http://fastsnp.ibms.sinica.edu.tw) [59] that is a web server-based
program designed for functional analysis of a SNP based on
information extracted from various biological databases and
analytical tools for SNP functional annotation. The program
predicts the most likely functions of a SNP according to 13
putative functional effects, such as changes to the transcriptional
level, pre-mRNA splicing, and protein structure alteration. The
advantage of the program is that the functional prediction for a
SNP is always based on the most up-to-date information extracted
from 11 external web servers at the time of query. However, since
the functional analysis of a SNP using FASTSNP is performed in
silico based on the flanking sequence of the SNP, the predicted
functions can only be viewed as putative and hypothetical and may
need further support from experimental work.
Imputation analysis for the CCR3 gene. The three CCR3
gene SNPs (rs13084656, rs2157056,a n drs2373156) with positive
association signals in our GWAS sample were not genotyped in the
previous CCR3 candidate gene study [16] for AAM. Therefore, to
facilitate comparison between this GWAS and the previous study
[16] in terms of the CCR3 gene’s importance to AAM,we performed
imputation analysis of the gene based on the genotype data generated
in our GWAS. Using the software IMPUTE [60] (http://www.stats.
ox.ac.uk/,marchini/software/gwas/impute.html), we imputed a
total of 1,380 SNPs covering the CCR3 gene and its neighborhood
regions. To ensure the reliability of the imputation, all of these
imputed SNP markers have reached a calling threshold of 0.90, i.e., a
90% probability that an imputed genotype is true. Based on the
imputed genotypes of these SNPs, we performed SNP association
analyses using the software SNPTEST (http://www.stats.ox.ac.uk/
,marchini/software/gwas/snptest.html) to obtain the ‘‘imputed’’ p
valuesforassociationwithAAMat these SNPsin our GWASsample.
Supporting Information
Figure S1 Results of analyses of potential population stratifica-
tion for the GWAS Cohort using Structure 2.2. As shown is output
of the software Structure 2.2, which clustered our study subjects
using 200 randomly selected unlinked markers under three
assumed numbers of population strata, k=2, 3, 4.
Found at: doi:10.1371/journal.pgen.1000420.s001 (0.06 MB PDF)
Figure S2 Q-Q plot for the p values achieved in the GWAS.
Found at: doi:10.1371/journal.pgen.1000420.s002 (0.03 MB PDF)
Figure S3 Haplotype block structure of the 7 AAM-associated
SPOCK gene SNPs in Caucasians. The haplotype block structure
was constructed using the HaploView software (http://www.
broad.mit.edu/mpg/haploview/) [53] and the most recent SNP
genotype data (HapMap Data Rel 26/phase III Nov 08, on NCBI
B36 assembly, dbSNP b126) from HapMap (www.hapmap.org).
The LD value between a certain pair of SNPs is shown within a
corresponding ‘‘square’’. A solid square without any value inside
means a complete LD between the corresponding pair of SNPs.
Found at: doi:10.1371/journal.pgen.1000420.s003 (0.03 MB PDF)
Table S1 SNPs of known genes that passed genome-wide
significant FDR threshold (q,0.05) in the GWAS.
Found at: doi:10.1371/journal.pgen.1000420.s004 (0.01 MB PDF)
Table S2 SPOCK SNPs and the p values for their association
with AAM. Labeled in bold are SNPs that are significant at the
genome-wide FDR level of 0.05 (q,0.05).
1The second allele
represents the minor allele of each locus.
2Minor allele frequency
calculated in our Caucasian study subjects.
3Minor allele
frequency reported for Caucasians in the public database of
HapMap CEU.
Found at: doi:10.1371/journal.pgen.1000420.s005 (0.03 MB PDF)
Table S3 Conditional association analysis of the 7 AAM-
associated SPOCK gene SNPs in the GWAS cohort. Block 1 and
block 2 are the haplotype blocks as shown in Figure S3. Original p
values are the p values achieved in regular association analysis for
AAM. P values for some SNPs cannot be estimated due to the high
LD between the SNPs and the SNP used as the covariate for
conditional analysis.
Found at: doi:10.1371/journal.pgen.1000420.s006 (0.02 MB PDF)
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